CUSIP: 75973T101
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
6,009,450
-
Share change
-
-362,346
-
Total reported value
-
$95,550,000
-
Put/Call ratio
-
69%
-
Price per share
-
$15.90
-
Number of holders
-
33
-
Value change
-
-$8,699,989
-
Number of buys
-
21
-
Number of sells
-
15
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 75973T101:
Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q4 2021
As of 31 Dec 2021,
Renalytix plc - ADS (RNLXY) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,009,450 shares.
The largest 10 holders included
GILDER GAGNON HOWE & CO LLC, Parian Global Management LP, Granahan Investment Management, LLC, FRED ALGER MANAGEMENT, LLC, Philosophy Capital Management LLC, PINNACLE ASSOCIATES LTD, Slate Path Capital LP, GOFEN & GLOSSBERG LLC /IL/, Pentwater Capital Management LP, and LAZARD ASSET MANAGEMENT LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.